NG_Freestyle Libre
Device
Abbott Laboratories
Total Payments
$2.9M
Transactions
341
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $2.9M | 341 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.9M | 341 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| FreeStyle Libre Flash Glucose Monitoring System Post Approval Study | Abbott Laboratories | $1.4M | 0 |
| FreeStyle Libre 3 Continuous Glucose Monitoring System Accuracy Study | Abbott Laboratories | $488,508 | 0 |
| Characterization Study of the Freestyle Libre Flash Glucose Monitoring System Using Capillary Glucose Reference | Abbott Laboratories | $309,874 | 0 |
| Effect of L-Ascorbic Acid on Accuracy of the FreeStyle Libre Flash Glucose Monitoring System | Abbott Laboratories | $295,718 | 0 |
| FreeStyle Libre Pro Flash Glucose Monitoring System Type 2 Basal Plus Study | Abbott Laboratories | $176,563 | 0 |
| Characterization Study of the Effect of L-Ascorbic Acid on the Accuracy of the FreeStyle Libre Flash Glucose Monitoring System | Abbott Laboratories | $87,221 | 0 |
| FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pediatric Patients - BG | Abbott Laboratories | $30,550 | 0 |
| Evaluation of the FreeStyle Libre CGM for the management of Gestational diabetes | Abbott Laboratories | $21,542 | 0 |
| Use of the FreeStyle Libre 2 Flash Glucose Monitoring System to Reduce Hyperglycemia in People with T2 Diabetes | Abbott Laboratories | $19,948 | 0 |
| FreeStyle Libre Flash Glucose Monitoring Systems and FreeStyle Libre Pro Flash Glucose Monitoring Systems | Abbott Laboratories | $17,887 | 0 |
| FreeStyle Libre Flash Glucose Monitoring System Using Capillary Glucose Reference | Abbott Laboratories | $7,500 | 0 |
| FreeStyle Libre blood glucose Flash Monitoring System | Abbott Laboratories | $3,458 | 0 |
| Impact of Joint Utilization of the FreeStyle Libre Flash Glucose Monitoring System and the Flairz Health App on Glycemic Control in Patients with Type 2 Diabetes Mellitus Managed with Prandial and Basal Insulin | Abbott Laboratories | $2,048 | 0 |
| FreeStyle Libre Flash Glucose Monitoring System Pediatric Accuracy Study | Abbott Laboratories | $1,000 | 0 |
| L-Ascorbic Acid C of the accuracy Study of the FreeStyle Libre Flash Glucose Monitoring System | Abbott Laboratories | $1,000 | 0 |
Top Doctors Receiving Payments for NG_Freestyle Libre
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Idaho Falls, ID | $2.9M | 341 |
Ad
Manufacturing Companies
- Abbott Laboratories $2.9M
Product Information
- Type Device
- Total Payments $2.9M
- Total Doctors 0
- Transactions 341
About NG_Freestyle Libre
NG_Freestyle Libre is a device associated with $2.9M in payments to 0 healthcare providers, recorded across 341 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $2.9M was paid across 341 transactions to 0 doctors.
The most common payment nature for NG_Freestyle Libre is "Unspecified" ($2.9M, 100.0% of total).
NG_Freestyle Libre is associated with 15 research studies, including "FreeStyle Libre Flash Glucose Monitoring System Post Approval Study" ($1.4M).